Cargando…
Nimesulide, a cyclooxygenase-2 selective inhibitor, suppresses obesity-related non-alcoholic fatty liver disease and hepatic insulin resistance through the regulation of peroxisome proliferator-activated receptor γ
Cyclooxygenase (COX)-2 selective inhibitors suppress non-alcoholic fatty liver disease (NAFLD); however, the precise mechanism of action remains unknown. The aim of this study was to examine how the COX-2 selective inhibitor nimesulide suppresses NAFLD in a murine model of high-fat diet (HFD)-induce...
Autores principales: | Tsujimoto, Shunsuke, Kishina, Manabu, Koda, Masahiko, Yamamoto, Yasutaka, Tanaka, Kohei, Harada, Yusuke, Yoshida, Akio, Hisatome, Ichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990319/ https://www.ncbi.nlm.nih.gov/pubmed/27431935 http://dx.doi.org/10.3892/ijmm.2016.2674 |
Ejemplares similares
-
Suppression of Intestinal Polyp Development by Nimesulide, a Selective Cyclooxygenase‐2 Inhibitor, in Min Mice
por: Nakatsugi, Seiichi, et al.
Publicado: (1997) -
Sulindac Derivatives That Activate the Peroxisome Proliferator-activated Receptor γ but Lack Cyclooxygenase Inhibition
por: Felts, Andrew S., et al.
Publicado: (2008) -
Effects of the cyclooxygenase-2 inhibitor nimesulide on cerebral infarction and neurological deficits induced by permanent middle cerebral artery occlusion in the rat
por: Candelario-Jalil, Eduardo, et al.
Publicado: (2005) -
Clinical implication of expression of cyclooxygenase-2 and peroxisome proliferator activated-receptor γ in epithelial ovarian tumours
por: Sakamoto, A, et al.
Publicado: (2004) -
A Series of microRNA in the Chromosome 14q32.2 Maternally Imprinted Region Related to Progression of Non-Alcoholic Fatty Liver Disease in a Mouse Model
por: Okamoto, Kinya, et al.
Publicado: (2016)